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Chapter 2. Methodology: Building the EED
Library and Undertaking a Systematic
Review of EED Biomarkers/Diagnostics
2.1 EED: A Broad Field, Many Unanswered
Questions
First, in collaboration with experts in the field, we developed a set of questions that
would be of primary importance to better understand and control EED. The scope was broad
and included environmental, nutritional, and other factors that might underlie EED, as well as
information related to EED pathogenesis. We framed these questions within six “topic areas”
(Table 2). We used these questions to guide our systematic literature search, seeking to identify
all references that could contribute to answering them. Prior to searching the literature for
relevant EED references, a search of the Cochrane Database of Systematic Reviews found no
Cochrane Reviews related to EED.

15

Table 2. Topic areas and questions.
The left column lists inclusive but circumscribed areas of relevance to EED, and the right
column presents questions relevant to each topic area. These formed the basis for the literature
search terms (Appendix 1).
Topic area

Questions

I. Epidemiology
of EED

What is the burden of disease represented by EED?
What is the prevalence of EED (including as measured by tests of gut
dysfunction or inflammation)?
1. What proportion of stunted/malnourished children have EED (as

measured by gut dysfunction/inflammation or infection with specific
microbes or identifiable microbial populations) or have a past history
of EED?
2. Other
II. EED,
malnutrition as
an outcome.
Associations,
risk factors,
protective
factors, causes
of acquisition of
EED,
malnutrition

What exposures/variables are associated with EED (including as measured
by tests of gut dysfunction or inflammation) or malnutrition/stunting? What
are the effect sizes (e.g., relative risk (RR), odd ratio (OR)) of the
associations? What are the causal pathways/mechanisms? Exclude
exposures related to food security/caloric density. Include:
3. Is infection with specific enteric pathogens (e.g., subsets of
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.

diarrheagenic E. coli, Cryptosporidium, Giardia) associated with EED
or malnutrition/stunting?
Are recurrent acute enteric infections/recurrent episodes of diarrhea
associated with EED or malnutrition/stunting?
Are persistent or chronic enteric infections/persistent diarrheal
episodes associated with EED or malnutrition/stunting?
Is exposure to/ingestion of fecal microbial populations (e.g., in
settings with lack of access to improved sanitation) associated with
EED or malnutrition/stunting?
Are other diseases/conditions including infections not predominantly
enteric in origin/manifestation (e.g., HIV, tuberculosis, malaria)
associated with EED or malnutrition/stunting?
Are environmental (e.g., water, sanitation, hygiene) factors
associated with EED or malnutrition/stunting?
Are social (e.g., socioeconomic status (SES), household
characteristics) or geographic (e.g., rural/urban) factors associated
with EED or malnutrition/stunting?
Are genetic factors associated with EED or malnutrition/stunting?
Are specific foods or nutrients (e.g., micronutrients (MNs), lack of
specific foods or nutrients, or specific feeding practices associated
with EED or malnutrition/stunting?
Are maternal factors (e.g., anemia in pregnancy, maternal short
stature) associated with EED or malnutrition/stunting?
Is low birth weight (LBW) or small for gestational age (SGA)
associated with EED or malnutrition/stunting?
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Topic area

Questions
14. Are microbially contaminated foods/lack of food safety or
contaminated bottles, feeding utensils, etc. associated with EED or
malnutrition/stunting?
15. Is malnutrition a risk factor for EED?
16. Other

III. EED as an
exposure.

What outcomes are associated with EED (including as measured by gut
dysfunction or inflammation or infection with specific microbes or identifiable
microbial populations)?

EED
association
with, risk factor
for, a cause of
subsequent
other child
health
problems.

17. Is EED a risk factor for malnutrition/stunting?
18. Is EED a risk factor for MN deficiencies—either multiple deficiencies
19.
20.
21.
22.
23.

IV.
Assessment,
biomarkers, and
diagnostics of
EED or
malnutrition

or isolated deficiencies (including zinc, vitamin A, iron, vitamin D,
folate, vitamin B12)?
Is EED a risk factor for overnutrition (including overweight and
obesity), especially later in childhood/adulthood?
Is EED a risk factor for subsequent enteric infections/diarrheal illness,
either in general or as caused by specific pathogens?
Is EED a risk factor for decreased oral vaccine efficacy or oral drug
efficacy?
Is EED a risk factor for diminished cognitive function or
developmental delay?
Other

24. What diagnostic tools or biomarkers are available to assess for EED

or malnutrition1? What biomarkers are manifest during the EED
clinical state that could be utilized to develop a diagnostic test?
Subquestions:

24a. How sensitive and specific is the test/biomarker in identifying the
child with EED compared to villous blunting with crypt hyperplasia on
histologic examination of small bowel biopsy intestinal biopsy? In the
absence of comparison to histology, how does the test/marker
compare to other diagnostic tests of gut function/dysfunction
including permeability, inflammation, or nutrient uptake?
24b. Does the marker or diagnostic allow grading of disease severity
or gut dysfunction?
24c. Is the diagnostic or biomarker field-friendly?
24d. What are the costs associated with the diagnostic/marker?

25. Other

V. EED Clinical
course, pathophysiology

26. What is the clinical course of EED (e.g., clinical symptoms, signs and

laboratory findings)? What are the underlying mechanisms/pathways
of these clinical changes?
27. What nutritional changes/abnormalities occur in EED including
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Topic area

Questions
energy metabolism, MN uptake, bioavailability and metabolism?
28. What gut pathophysiology, histology or cellular changes are found in
EED?
29. Other

VI. EED,
malnutrition
interventions—
prevention and
treatment

What interventions can prevent, treat or mitigate EED (including as
measured by tests of gut dysfunction or inflammation) or
stunting/malnutrition? What is the effect2 of interventions in reducing
prevalence of EED or malnutrition among children (compared to no
intervention or placebo intervention)? What is the effect of interventions on
treating or mitigating the impact of EED (outcomes could include diminished
gut inflammation, diminished microbial content in host guts, improved gut
function) or stunting/malnutrition (outcomes could include improved linear
growth or weight gain) among individual children? For each treatment
intervention identified, what is the effect in impacting outcomes compared to
no intervention or placebo intervention3?
Exclude interventions related to increased calorie intake or food security.
Interventions include:
Population-based interventions among asymptomatic children in
developing-country settings:
30. Zinc, vitamin A, folic acid, vitamin B12 supplementation or
31.
32.
33.
34.
35.
36.
37.
38.
39.

fortification4 (or supplementation or fortification with other MNs or with
multiple MNs)
Interventions related to breastfeeding
Nutritional interventions such as introduction of or increased
consumption of certain foods, including weaning or complementary
foods
Feeding practices (e.g., responsive feeding practices among
caretakers)
Improved food safety (e.g., boiling eating utensils, improved food
storage and reheating)
Improved water, sanitation, hygiene
Prebiotics, probiotics
Maternal interventions (e.g., prenatal iron/folate supplements in
pregnancy and examination of impact on EED or malnutrition in
offspring)
Health services interventions (e.g., implementation of growth
monitoring programs, cash transfers in return for care-seeking)
Other

Interventions to prevent EED implemented among children in
developing-country settings with specific symptoms (e.g., diarrhea):
40. Zinc, vitamin A, folic acid, vitamin B12, or other MNs (e.g., for

treatment of diarrhea)

41. Prebiotics, probiotics (e.g., for treatment diarrhea)
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Topic area

Questions
42. Management/treatment of other conditions (e.g., antitubercular
agents, tuberculosis, antiretrovirals for HIV, antimalarials to treat
malaria infections, intermittent preventive treatment of malaria)
43. Other
Among children identified/diagnosed as having EED or malnutrition:
44. Treatment with specific MNs including: iron, zinc, vitamin A, vitamin
D, folic acid, vitamin B12
45. Treatment with multiple MN preparations (e.g., Sprinkles)
46. Treatment with antibiotics
47. Treatment with probiotics
48. Nutritional interventions such as introduction or increased
consumption of specific foods; ready-to-use therapeutic or
supplementary foods; related nutritional therapeutics
49. Feeding practices (e.g., responsive feeding practices among
caretakers)
50. Other

1

Not including measures of physical growth (e.g., height, weight, mid upper arm circumference), indices
calculated from measures of physical growth (e.g., body surface area), or use of growth charts or growth
standards.
2
Including any potential harms identified with the intervention. Furthermore, cost information should be
captured where available.
3
Where possible, also identify the best stage in the EED clinical spectrum in which to intervene and at
which stage does therapeutic effect have the greatest impact on outcomes compared to other stages?
4
Supplementation defined as administration of MNs to a population subgroup based on age or other life
cycle factors. E.g., prenatal vitamins, giving 6-36 month-olds vitamin A capsule every six months.
Fortification defined as adding MNs to food staples such as the addition of folate to flour.

A “wide-net” broadly inclusive systematic search strategy was considered necessary at
project inception in order to capture sufficient references of relevance for four reasons: (1) a
wide scope and breadth of questions were deemed of interest for potential systematic
investigation; (2) we believed that there would likely be modified or derivative questions after the
initial review was performed; (3) EED has a broad, indistinct, and historically variable definition;
and (4) specific search terms for EED, ED or even enteropathy do not exist in the medical and
health databases. Because the effort involved in searching for articles solely related to one EED
systematic review question would only be marginally more compared to searching more broadly
for articles to address a wide range of EED-related questions, we opted for an infrastructure that
could produce a systematic review product efficiently and expediently.
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2.2 Constructing a Systematic Search Strategy:
Optimizing Sensitivity
We devised a systematic and comprehensive search, extraction, and analysis strategy.
Our overall procedure is depicted in Figure 4. We now describe the process components.
The first step was the construction of a comprehensive, systematic search strategy. We
developed individual search strategies for each database with the assistance of a research
librarian at the World Health Organization in Geneva. We devised a two-step search strategy
that was extensive due to the broadly defined nature of EED and the lack of robust indexing of
search terms across databases (as described above) (Appendix 1). In the first step, we used
broad terms to capture all references related to EED, including similar or identical disorders
(‘tropical enteropathy’, ‘environmental enteropathy’, ‘tropical sprue’, ‘tropical malabsorption
syndrome’, and ‘malabsorption’, ’enteropathy’, or ‘intestinal dysfunction’ in the tropics). At first
pass, we included any age group and any setting (e.g., returned travelers), because these
publications could conceivably contain data that provide some understanding of aspects of
EED. We were also interested in other enteropathies among children under five years of age
in developing countries, such as celiac disease or Crohn’s disease, because these disorders
might have been misdiagnosed EED, or because tests employed could be relevant to EED in
children at risk in resource-poor areas of the world.
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Figure 4. EED systematic review processes flow chart.
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As the second step, we identified references about malnutrition or nutritional status (as
measured by anthropometrics) among children under five years of age in developing countries.
The goal was to identify scenarios where EED is an intermediary: nutritional status as an
outcome of enteric dysfunction, biochemical or radiologic biomarkers/diagnostics of nutritional
status, or interventions to prevent or treat malnutrition. For nutritional outcomes, we limited our
search to effects on anthropometric indices (e.g., height-for-age, weight-for-age, weight-forheight, mid-upper arm circumference, and growth velocity). We excluded articles strictly about
prevalence or incidence of malnutrition (i.e., containing no information about risk factors
associated with nutritional status), articles about non-EED outcomes of malnutrition/nutritional
status, and articles examining the utility of anthropometric measures.
Next, we constructed search strategies to query the most relevant medical and health
databases: PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), Embase
(http://www.embase.com/), Global Health (database published by Centre for Agriculture and
Biosciences International (CABI)), and the WHO regional databases. We included Global Health
and the WHO databases because of their higher proportions of articles from resource-poor
regions, which are often not published in journals that are indexed in PubMed and Embase.
Additionally, the WHO regional databases contain much “gray” literature from government and
nongovernmental organizations that could have been of relevance.
To ensure that our search adequately identified relevant references, we developed a test
set of references obtained by identifying 20 key EED references in collaboration with two
external advisors with content expertise (Appendix 2).
We sought to retain as many relevant references in our search results as possible, while
minimizing extraneous and irrelevant information. To maintain specificity, we filtered the
references for data from developing countries, tropical settings, or indigenous populations.
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However, universal use of this filter resulted in test EED references being missed. We were,
however, able to use the filter on the malnutrition search strategy without losing relevant
articles. We were able to apply another filter to restrict malnutrition articles to those related to
children. We did not restrict language or year of publication. After these modifications to our
search strategy, 18 of the 20 test references were captured. To detect the remaining two
articles, we would have needed to use a strategy that yielded a ten-fold increase in the number
of articles returned in the search. On further scrutiny, this problem was caused by a lack of
sensitive index terms for one article [87] and lack of child terms for the other [57] (Appendix 2).
We accepted this compromise, recognizing that the “snowball” technique (described below)
would increase our search sensitivity.
With our approach, we were able to interrogate the literature on a topic that is both
poorly defined and poorly indexed. Our comprehensive, rigorously evaluated, and reproducible
methodology can be utilized as a systematic search model approach for other topics that are
similarly broad and/or diffusely defined or cataloged, for which standard systematic search
techniques would be insufficient and imprecise.

2.3 Reference Volume Mitigation
The systematic search, completed June 2010, identified a total of 85,334 references
(after identifying and removing references that were duplicated within the four databases that
were searched), dating back to 1910 (discussed further in Results section). This overwhelming
volume of potentially relevant literature was unexpected, and we briefly considered using only
references from recent review articles on the topic. This was not possible, however, because no
previous systematic reviews had been published with which to identify biomarkers that could be
used to prevent and treat, or to guide rehabilitation from, intestinal dysfunction in children in
resource-limited countries. Some reviews [8, 45, 88-93] either focused on adults or on narrow
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components of the problems, and not diagnostic strategies. Hence, this “look back” literature
review strategy would not have yielded the information we were seeking.
We next considered two options relevant to processing the ca. 85,000 titles. The first
option was to scrutinize this very long list with only one or two questions in mind, and vote on
each as presumptive “include” or “exclude” related only to the limited inquiry, and ignore all
irrelevant topic areas and corresponding questions (“limited-use scrutiny”). The second option
was to build an EED Library with references with notation of its relevance to any of the potential
topic area(s) and questions (“future use scrutiny”). The third option was to scrutinize each
reference, and then note the relevance only at the topic level, and not identify the specific
questions that each reference might address. Table 3 summarizes the advantages and
disadvantages of each approach.
After careful consideration, we decided to use a “modified future use” approach, i.e.,
examine each reference for its relevance to each of the six target areas, but not drill down to the
question level. However, we left questions available to the analysts as guides to the potential
utility of each document. We recognized that this approach entailed more analyst labor, i.e.,
approximately 200 additional person hours (assuming two readings of each listing) compared to
the first strategy in Table 3 (these estimates are limited to the review of the reference lists).
However, the hours of effort per question potentially answered would be considerably fewer,
when considering that the comprehensive scoring would encompass topic areas that include a
total of 49 potentially useful questions.
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Table 3. Summary of analysis options.
Advantages and disadvantages of comprehensive versus targeted analysis of literature
produced by search terms are portrayed.
Strategy

Advantages

Disadvantages

1. Targeted (“single use”)
scrutiny of 85,000
references (focus on only
1 or 2 possible uses
of/questions for
database)

Reduced time per reference,
based on an estimate of 0.75
hour for 1 analyst to scrutinize
200 references, and all
references are independently
reviewed by two analysts, for
a total of 637 person hours

Cannot be used for more than
a very limited number of
questions (estimated 2 at
most)

2. Broad (“future use”)
scrutiny (focus on all
possible topic areas, and
denote particular
questions)

Diminishes need to repeat
scrutiny of references, and
generates candidate
documents for all potential
topic areas and questions

Extended time per reference
compared to strategy 1
(based on an estimate of 1.75
hours for 1 analyst to
scrutinize 200 references, and
all references are reviewed by
two analysts), for a total of
1488 hours

3. Broad (“modified future
use”) scrutiny (focus on
all possible topic areas,
but do not denote
particular questions)

Diminishes need to repeat
scrutiny of references, and
generates candidate
documents for all potential
topic areas, but not questions

Extended time per reference
compared to strategy 1
(based on an estimate of 1.25
hours for 1 analyst to
scrutinize 200 references, and
all references are reviewed by
two analysts), for a total of
1,063 person hours

2.4 Building the EED Library
The initial list of approximately 85,000 references from the processes described above
contained the following information from the databases searched: title, authors, journal, and to
varying extents, abstracts. We exported the references from PubMed, EMBASE and Global
Health into EndNote software (ca. 81,000); this was not possible with the references from the
WHO Regional libraries (ca. 4,000) because of the format in which these references were
exported from the search engine.
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References from all of these sources were reviewed by research analyst (RA) pairs
comprised of individuals trained in epidemiology or nutritional sciences, and who received
extensive training in our protocol for inclusion/exclusion of studies.
Per standard systematic review methodology, each reference (title, keywords, and
abstract when available) was reviewed by two analysts to determine inclusion status for the
EED Library. Dual review reduces bias and inaccuracies in the systematic review process. The
principal investigators (DMD and PIT) initially piloted the Library inclusion process, until 100%
concordance was achieved upon independent review of 1,300 consecutive references. A series
of training sessions to convey the goals of the project, along with a protocol with which to
determine inclusion of a reference in the EED Library, were provided to the team of RAs. Verbal
and written instructions were conveyed to the analysts (Table 4), and a schematic regarding
articles to include, and under what category, was also provided (Figure 5).
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Table 4. Summary of EED Library inclusion/exclusion instructions to research analysts.
Each analyst was instructed in the scope of interest of the EED Library, and how to code, tag
and label data related to each reference included in the EED Library.

A reference was included if it pertained to any of the following conditions:
•
•
•
•
•
•

Environmental Enteric Dysfunction
Tropical Enteropathy
Tropical Sprue
Environmental Enteropathy
Tropical Malabsorption Syndrome
Malabsorption/Enteropathy/Enteric Dysfunction in resource-limited settings

Any age group and any setting (e.g., travelers) were eligible for this filter step.
References about other enteropathies were included only if among children under five in
developing countries (e.g., celiac disease, inflammatory bowel disease (IBD)).
Nutrition-related articles were included if:
•
•
•

Malnutrition or nutritional status (as measured by anthropometrics) among children
under five in developing country was an outcome
The study pertained to biochemical diagnostics or biomarkers or radiographic or
other imaging among children under five in a developing country
The study used interventions to prevent or treat malnutrition, even if the outcome
was something other than change in nutritional status or prevalence of malnutrition.
Interventions were eligible only if they started among children under five years,
even if outcomes were measured at a later age.

A separate category of inclusion captured relevant reviews; this was defined broadly to include
review articles, meta-analyses, editorials, commentaries, compendia or conference
proceedings, letters, books, or book chapters.

Exclusions:
•
•
•

prevalence, incidence, etc. of malnutrition if there was no information about factors
(other than caloric insufficiency/food insecurity) associated with nutritional status
outcomes specifically due to malnutrition/nutritional status
the utilization of anthropometric measures
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Further delineation of relevance to our systematic review
Topic areas:
I. Epidemiology of EED
II. EED or malnutrition as an outcome
Any associations, risk factors, protective factors, causes of acquisition of EED,
malnutrition (except for food insecurity/inadequate calories associated with malnutrition).
III. EED as an exposure
EED as an association with, risk factor for, or cause of subsequent other child health
problems.
IV. Assessment, biomarkers, and diagnostics of EED or malnutrition
V. EED clinical course, pathophysiology
VI. EED or malnutrition interventions
Relevant studies included in the EED Library:
•
•
•

•

Exposures, risk factors, protective factors, host factors, prevention or treatment
interventions (other than those related to caloric density or food security), and their
impact on EED or malnutrition outcomes.
Diagnostic tests or biomarkers related to, or to assess for, EED or malnutrition.
Interventions (other than those related to caloric density or food security) to prevent or
treat malnutrition in children under five years, even if the outcome was something other
than change in prevalence of malnutrition or change in nutritional status of individual
children. Outcomes could include, for example, change in case fatality rate. Outcomes
measured beyond five years were also included.
Prevalence, clinical course, and pathophysiology of EED.

References we excluded from the EED Library:
•

•
•

Malnutrition as a risk factor for other morbidities/outcomes (e.g., malnutrition as a risk
factor for pneumonia, stunting as a risk factor for obesity or mortality in adulthood,
malnutrition as a risk factor for childhood mortality) unless the outcome was EED (e.g.,
malnutrition as a risk factor for poor intestinal function was included)
Malnutrition prevalence studies--unless they also examined risk factors for malnutrition
or were intervention studies where change in prevalence of malnutrition is an outcome.
Measures/indices of physical growth such as growth charts or use of new indices
calculated based on height, weight, or other physical measurements.
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Figure 5. EED Library inclusion schematic.
Analysts used this as a guide in determining which references should be included in the EED
Library.

Feedback on nuances of the inclusion protocol was communicated to the analysts on a
regular basis for the duration of the project. Table 5 contains samples of such guidance.
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Table 5. Additional EED Library inclusion/exclusion guidance and tips.
The EED category was intentionally defined broadly. The term environmental enteric
dysfunction (EED) has several potential equivalents in the literature, including tropical
enteropathy, environmental enteropathy, tropical sprue, and tropical malabsorption syndrome.
We also included references about enteric dysfunction and any other enteropathy impacting
children in developing countries. These enteric conditions included kwashiorkor enteropathy,
HIV enteropathy, tuberculosis enteropathy, celiac disease, inflammatory bowel disease, and
other enteropathies, assuming they occurred in a developing-country setting.
References were included even if our outcomes of interest were not the study's primary focus.
If the title or abstract clearly indicated that the outcome was acute diarrhea, acute gastroenteritis
or an acute enteric infection, we excluded it. If the reference noted they specifically examined
persistent or chronic diarrhea as an outcome, it was included. Even if the main outcome studied
was acute diarrhea, the reference was included if it examined EED or persistent/chronic
diarrhea as a "minor" outcome. If an outcome of "diarrhea" was not specified as either acute or
persistent/chronic, we assumed the article referred to acute diarrhea and we excluded it.
References about acute diarrhea were included when they examined the impact of acute
diarrheal illness or acute gastroenteritis on EED or malnutrition.
References about children with IBD or celiac disease originating in a developing country were
included (but excluded if the study was conducted in a developed country). Even though the
origin of IBD and celiac disease is distinct from EED, we included it from developing-country
settings for two reasons:
a. Celiac disease or IBD in developing countries may truly be misdiagnosed EED, a fact
we will be better able to judge when reading the study methodology.
b. We are attempting to look at enteric dysfunction in developing settings more broadly
and with fresh perspectives, to allow new observations of underlying patterns.
While enteropathy is not always a manifestation of tuberculosis, HIV, or kwashiorkor, if a study
in a developing country discussed enteric dysfunction or enteropathy related to these
conditions, we included it.
We excluded studies that reported prevalence of infection with a specific pathogen. If a study
examined a pathogen's association with EED or other outcomes of interest as previously
specified, then we included it.
We focused on small intestine pathology; therefore, we excluded studies looking at
gastric/colonic pathology unless they also examined outcomes pertaining to the small intestine.
References about gastrointestinal problems that are not EED-related were excluded; a nonexhaustive list of commonly encountered conditions not included in our review includes:
•
•
•
•
•

Appendicitis
Blind loop syndrome
Colonic atresia
Duodenal atresia
Dyspepsia
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•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Hemolytic uremic syndrome
Henoch-Schonlein purpura
Hirschsprung's disease
Intestinal obstruction
Intussusception
Irritable bowel syndrome
Malrotation
Necrotizing enterocolitis
Perirectal abscess
Peritonitis
Primary bile acid malabsorption
Pseudomembranous colitis
Rectal prolapse
Short bowel syndrome
Volvulus

We included studies examining potential risk/protective factors for stunting, wasting or other
forms of malnutrition, except those related to food security or caloric density. We excluded
studies where any type of malnutrition was considered the exposure, unless EED was an
outcome.
Articles examining factors associated with anthropometric/growth outcomes were included even
if not related to malnutrition. We did not include articles that solely examined the outcomes of
overweight and obesity (unless related to EED), but studies of changes in growth status among
children under five in developing countries were included. We excluded anthropometric data
collected for the purpose of evaluating national statistics (e.g., in relation to WHO child growth
standards) and studies of malnutrition or nutritional status prevalence unless the studies also
looked at risk or protective factors associated with EED.
Growth outcomes among children with common chronic infectious diseases such as HIV or
hepatitis were considered outcomes of interest.
We included any potential risk or protective factors for EED, malnutrition, or other outcomes of
interest, even if they are not necessarily directly related to gut dysfunction, e.g., poverty,
domestic violence, maternal anemia, small for gestational age (SGA), or low birth weight (LBW).
We excluded studies where SGA or LBW was the study outcome, however.
We included genetic risk factors for EED, malnutrition, or another related outcome of interest as
long the study was conducted in a developing-country setting.
Many studies contain relevant information about children under five even though they are not
restricted to— or even focusing on— that age group. If any children under five were included,
we included the reference.
If a relevant study was conducted in a year when the study country was on the developing
country list, it was included.
We excluded case reports (or in vitro lab or animal model studies) even if relevant to EED.
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The analysts were provided guidelines on inclusion and exclusion criteria. They were
further instructed to: include only references from work performed in low- and middle-income
countries (per World Bank definitions during the time that the data in the reference were
collected) or among marginalized or indigenous populations in developed countries (e.g.,
Aboriginal Australian children) [94, 95]; to include references related to EED or conditions
identical to or very consistent with EED (e.g., environmental enteropathy, tropical enteropathy,
persistent diarrhea) among any age group in a setting of interest, and references related to
other enteropathies or to nutritional conditions of interest among children under five years of age
in a setting of interest.
The refinements in the inclusion/exclusion instructions regarding other enteropathies
were implemented because there is accumulating evidence that celiac disease is not confined
to individuals of northern European descent residing in industrialized countries, but is instead a
worldwide problem, including in regions in which EED is endemic, such as South Asia [96].
Second, there is increasing recognition of inflammatory bowel diseases (i.e., Crohn’s disease
and ulcerative colitis) in these regions [97], though most cases of intestinal inflammation in
these populations are not related to idiopathic inflammatory bowel diseases in children under
five years of age. Third, we wished to include references on malnutrition and nutritional status
where EED could act as an intermediary while excluding references that examined other
aspects of malnutrition. For example, while food insecurity commonly affects populations at risk
for EED, studies of nutritional deficits by themselves, including surveys of such deficiencies,
were designated to be beyond the scope of our project. In another example, iron deficiency can
be caused by a multitude of factors including defective absorptive capacity in the small bowel.
To capture only the references relating to intestinal absorptive function, we excluded references
if iron deficiency was studied outside the context of intestinal uptake assessment or another
process related to EED.
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Progressing in reverse chronological order, virtually all references between 1980 and
2010 were evaluated as to whether or not they should be included or excluded from the EED
Library, or whether or not additional information from the full text (particularly when the abstract
was not initially available from the medical/health databases searched) was needed to make the
determination. If included in the Library, references were assigned tags as to whether the
reference contained information about: 1) enteropathy or enteric function/dysfunction, 2)
nutritional status or malnutrition, and/or 3) enteric microbes. By using the topic areas and tags,
we could then formulate queries to apply to our EED Library to identify articles potentially
relevant to specific review questions that are contained in Table 2 or identified in the future.
Additionally, topic areas (Table 2) covered in each reference were noted, as well as an
indication whether the reference was a review or otherwise did not present primary data.
Each reference published between 1980 and 2010 was reviewed for inclusion by two
analysts according to the written guidelines and instructions. A principal investigator or lead
analyst reviewed all references for which the analysts were discordant on Library inclusion, topic
area, or other determinations, and provided final decisions. Furthermore, to verify that
systematic errors did not occur in the exclusion of references, a random subset of references
excluded by both analysts was scrutinized by a lead analyst. Percent error rate for this subset
was calculated.
The kappa statistic was used to evaluate reliability of individual analyst responses
against final inclusion/exclusion determinations. Interpretation of kappa was performed using
the following guidelines as described by Koepsell and Weiss [98]: agreement of >0.80 was
deemed excellent, 0.61-0.80 substantial, 0.41-0.60 moderate, 0.21-0.40 fair, 0.00-0.20 slight,
and <0.00 poor.
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